Intellectus Partners LLC Has $204,000 Stock Position in UiPath Inc. (NYSE:PATH)

Intellectus Partners LLC cut its stake in shares of UiPath Inc. (NYSE:PATH) by 14.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 15,907 shares of the healthcare company’s stock after selling 2,650 shares during the quarter. Intellectus Partners LLC’s holdings in UiPath were worth $204,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Oppenheimer & Co. Inc. increased its stake in shares of UiPath by 5.2% in the third quarter. Oppenheimer & Co. Inc. now owns 195,641 shares of the healthcare company’s stock valued at $2,504,000 after buying an additional 9,709 shares during the period. Nations Financial Group Inc. IA ADV grew its holdings in UiPath by 6.8% during the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 26,090 shares of the healthcare company’s stock worth $334,000 after acquiring an additional 1,654 shares during the last quarter. Versor Investments LP acquired a new position in UiPath in the 3rd quarter valued at approximately $266,000. State of New Jersey Common Pension Fund D lifted its holdings in shares of UiPath by 7.1% during the third quarter. State of New Jersey Common Pension Fund D now owns 179,083 shares of the healthcare company’s stock worth $2,292,000 after purchasing an additional 11,810 shares during the period. Finally, River Global Investors LLP grew its stake in shares of UiPath by 4.1% in the third quarter. River Global Investors LLP now owns 165,582 shares of the healthcare company’s stock worth $2,119,000 after purchasing an additional 6,486 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors.

UiPath Trading Down 2.1 %

PATH opened at $12.37 on Friday. The company has a market cap of $6.80 billion, a price-to-earnings ratio of -61.85 and a beta of 0.87. The company’s fifty day moving average price is $12.61 and its two-hundred day moving average price is $13.42. UiPath Inc. has a 1-year low of $10.37 and a 1-year high of $27.87.

UiPath (NYSE:PATH) last posted its earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. The company had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The firm’s revenue was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.09) EPS. As a group, equities analysts forecast that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have commented on PATH shares. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $16.00 target price on shares of UiPath in a report on Friday, September 6th. Wells Fargo & Company reduced their target price on UiPath from $15.00 to $13.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd. BMO Capital Markets boosted their price target on shares of UiPath from $14.00 to $15.00 and gave the stock a “market perform” rating in a research report on Friday, September 6th. DA Davidson increased their price objective on shares of UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $15.00 price target on shares of UiPath in a research report on Friday, September 6th. Sixteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, UiPath has a consensus rating of “Hold” and a consensus price target of $17.47.

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of the firm’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $12.07, for a total transaction of $575,388.97. Following the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at $10,258,498.19. This trade represents a 5.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 22.37% of the stock is owned by insiders.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.